Literature DB >> 31477326

MiR-1193 was sponged by LINC00963 and inhibited cutaneous squamous cell carcinoma progression by targeting SOX4.

Jingwen Wang1, Chao Li2, Lifa Xu3, ChunJun Yang4, Xuejun Zhang5.   

Abstract

Cutaneous squamous cell carcinoma (CSCC), a class of skin tumor derived from epidermal keratinocyte, is reputed as one of the most malignant tumors globally. MicroRNAs (miRNAs) are increasingly identified as essential players in CSCC. Current study aimed to uncover the impact and mechanism of miR-1193 in CSCC. We identified the low expression of miR-1193 in CSCC cell lines. Gain- and loss-of-function assays showed that miR-1193 acted as an inhibitor of proliferation and migration in CSCC cells. Furthermore, we illustrated that miR-1193 targeted and inhibited SRY-box 4 (SOX4), and that long intergenic non-protein coding RNA 963 (LINC00963) sponged miR-1193 to upregulate SOX4 expression. Rescue assays showed that LINC00963 regulated CSCC progression through miR-1193/SOX4 axis. In conclusion, our study firstly revealed the LINC00963/miR-1193/SOX4 axis in CSCC, indicating miR-1193 as a promising biological target in CSCC progression.
Copyright © 2019 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  Cutaneous squamous cell carcinoma; LINC00963; SOX4; miR-1193

Mesh:

Substances:

Year:  2019        PMID: 31477326     DOI: 10.1016/j.prp.2019.152600

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  13 in total

1.  Development and Validation of a Novel Ferroptosis-Related LncRNA Signature for Predicting Prognosis and the Immune Landscape Features in Uveal Melanoma.

Authors:  Xiaochen Ma; Sejie Yu; Bin Zhao; Wei Bai; Yubo Cui; Jinglan Ni; Qinghua Lyu; Jun Zhao
Journal:  Front Immunol       Date:  2022-06-14       Impact factor: 8.786

2.  CircRNA circ_0067772 aggravates the malignant progression of cutaneous squamous cell carcinoma by regulating miR-1238-3p/FOXG1 axis.

Authors:  Xiaoqing Li; Yinghui Kong; He Li; Manyuan Xu; Ming Jiang; Weiguo Sun; Suping Xu
Journal:  Genes Genomics       Date:  2021-03-11       Impact factor: 1.839

3.  LINC00963 Functions as an Oncogene in Bladder Cancer by Regulating the miR-766-3p/MTA1 Axis.

Authors:  Ning Zhou; Xiaofei Zhu; Libo Man
Journal:  Cancer Manag Res       Date:  2020-05-12       Impact factor: 3.989

4.  LINC00963 Confers Oncogenic Properties in Glioma by Regulating the miR-506/BCAT1 Axis.

Authors:  Feng Ye; Ronghua Xu; Yuanhong Ge; Yi Zheng; Xiaowei Liu; Pingfu Deng; Xuejun Xu
Journal:  Cancer Manag Res       Date:  2020-03-27       Impact factor: 3.989

5.  lncRNA LINC00963 downregulation regulates colorectal cancer tumorigenesis and progression via the miR‑10b/FGF13 axis.

Authors:  Yujin Wu; Longling Cong; Wenjian Chen; Xuechuan Wang; Fanghua Qiu
Journal:  Mol Med Rep       Date:  2021-01-26       Impact factor: 2.952

6.  Circular RNA circSEC24A Promotes Cutaneous Squamous Cell Carcinoma Progression by Regulating miR-1193/MAP3K9 Axis.

Authors:  Xiaoyan Lu; Quan Gan; Caibin Gan
Journal:  Onco Targets Ther       Date:  2021-01-22       Impact factor: 4.147

7.  The regulation of miR-320a/XBP1 axis through LINC00963 for endoplasmic reticulum stress and autophagy in diffuse large B-cell lymphoma.

Authors:  Yuying Cui; Hui Xu; Yu Yang; Dongmei Zhao; Yu Wen; Chao Lv; Hongbin Qiu; Chennan Wang
Journal:  Cancer Cell Int       Date:  2021-06-10       Impact factor: 5.722

8.  Circ_0061140 stimulates the malignant development of prostate cancer by targeting miR-1193.

Authors:  Kai Wang; Yi Fan; Ji Sun; Liwei Zhao; Yufu Yu; Gonghui Li
Journal:  Transl Androl Urol       Date:  2021-05

9.  MiR-1193 Inhibits the Malignancy of Cervical Cancer Cells by Targeting Claudin 7 (CLDN7).

Authors:  Bin Zhang; Yao Lin; Qiufang Bao; Yantong Zheng; Lan Lan
Journal:  Onco Targets Ther       Date:  2020-05-19       Impact factor: 4.147

10.  LINC00963 facilitates acute myeloid leukemia development by modulating miR-608/MMP-15.

Authors:  Wenli Zuo; Keshu Zhou; Mei Deng; Quande Lin; Qingsong Yin; Chunlei Zhang; Jian Zhou; Yongping Song
Journal:  Aging (Albany NY)       Date:  2020-10-04       Impact factor: 5.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.